文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19相关急性呼吸窘迫综合征的早期俯卧位通气:来自多中心COVID-ICU网络队列的倾向性评分分析—ProneCOVID研究

Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network-the ProneCOVID study.
PubMed 文献 · Crit Care · 2022-03-24
一句话结论在因COVID-19 ARDS插管的ICU患者中,入住ICU 24小时内启动的早期俯卧位通气与第1天后的俯卧位相比,未显示第60天生存获益(校正后HR 1.34,95%CI 0.96-1.68,p=0.09)。

本研究为COVID-ICU网络前瞻性多中心队列的二次分析,纳入法国、比利时和瑞士149个ICU中因COVID-19 ARDS插管的患者,随访至第90天。2137例插管患者中,1504例(70.4%)在ICU期间接受俯卧位通气,491例(23%)在入住ICU后24小时内接受俯卧位通气。早期俯卧位组第60天死亡率为39.3%,非早期俯卧位组为34.2%(p=0.038);倾向性评分校正后,两组第60天生存无显著差异(完整病例分析HR 1.34,95%CI 0.96-1.68,p=0.09;多重插补分析HR 1.19,95%CI 0.998-1.412,p=0.053)。作者认为,数据未能显示对所有需要有创机械通气的COVID-19患者,入住ICU 24小时内启动的早期俯卧位通气较第1天后俯卧位通气带来生存获益。

要点

  • 在2137例因COVID-19 ARDS插管的患者中,1504例(70.4%)在ICU期间接受俯卧位通气,其中491例(23%)在入住ICU后24小时内启动。
  • 早期俯卧位组第60天死亡率为39.3%,非早期俯卧位组为34.2%(p=0.038);倾向性评分校正后第60天生存无显著差异(完整病例分析HR 1.34,95%CI 0.96-1.68,p=0.09;多重插补分析HR 1.19,95%CI 0.998-1.412,p=0.053)。
  • 早期俯卧位组第28天和第90天死亡率及辅助治疗需求更高。
  • 早期俯卧位组中181例(36.9%)在启动俯卧位时PaO2/FiO2比值>150 mmHg;非早期俯卧位组中1013例(47.4%)最终接受俯卧位通气,中位延迟为入住ICU后3天。
  • 作者认为,数据未能显示对所有需要有创机械通气的COVID-19患者,早期俯卧位通气(入住ICU 24小时内启动)较第1天后俯卧位通气带来生存获益。

适用人群与场景

  • 因COVID-19 ARDS插管的成人患者,来自法国、比利时和瑞士149个ICU的前瞻性多中心队列(COVID-ICU网络),随访至第90天。

研究设计与关键结果

  • 研究类型:前瞻性多中心队列研究的二次分析,纳入149个ICU,共2137例插管患者。
  • 俯卧位通气使用情况:1504例(70.4%)在ICU期间接受俯卧位通气,491例(23%)在入住ICU后24小时内启动(早期俯卧位组)。
  • 早期俯卧位组中181例(36.9%)在启动俯卧位时PaO2/FiO2比值>150 mmHg。
  • 非早期俯卧位组中1013例(47.4%)最终接受俯卧位通气,中位延迟为入住ICU后3天。
  • 主要终点:第60天死亡率早期俯卧位组39.3% vs 非早期俯卧位组34.2%(p=0.038);倾向性评分校正后第60天生存无显著差异:完整病例分析HR 1.34(95%CI 0.96-1.68),p=0.09;多重插补分析HR 1.19(95%CI 0.998-1.412),p=0.053。
  • 次要终点:早期俯卧位组第28天和第90天死亡率及辅助治疗需求更高。

证据类型、等级与局限

  • 证据类型:前瞻性多中心队列研究的二次分析(倾向性评分分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,数据未能显示对所有需要有创机械通气的COVID-19患者,入住ICU 24小时内启动的早期俯卧位通气较第1天后俯卧位通气带来生存获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Delaying time to prone positioning (PP) may be associated with higher mortality in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). We evaluated the use and the impact of early PP on clinical outcomes in intubated patients hospitalized in intensive care units (ICUs) for COVID-19.

METHODS: All intubated patients with ARDS due to COVID-19 were involved in a secondary analysis from a prospective multicenter cohort study of COVID-ICU network including 149 ICUs across France, Belgium and Switzerland. Patients were followed-up until Day-90. The primary outcome was survival at Day-60. Analysis used a Cox proportional hazard model including a propensity score.

RESULTS: Among 2137 intubated patients, 1504 (70.4%) were placed in PP during their ICU stay and 491 (23%) during the first 24 h following ICU admission. One hundred and eighty-one patients (36.9%) of the early PP group had a PaO2/FiO2 ratio > 150 mmHg when prone positioning was initiated. Among non-early PP group patients, 1013 (47.4%) patients had finally been placed in PP within a median delay of 3 days after ICU admission. Day-60 mortality in non-early PP group was 34.2% versus 39.3% in the early PP group (p = 0.038). Day-28 and Day-90 mortality as well as the need for adjunctive therapies was more important in patients with early PP. After propensity score adjustment, no significant difference in survival at Day-60 was found between the two study groups (HR 1.34 [0.96-1.68], p = 0.09 and HR 1.19 [0.998-1.412], p = 0.053 in complete case analysis or in multiple imputation analysis, respectively).

CONCLUSIONS: In a large multicentric international cohort of intubated ICU patients with ARDS due to COVID-19, PP has been used frequently as a main treatment. In this study, our data failed to show a survival benefit associated with early PP started within 24 h after ICU admission compared to PP after day-1 for all COVID-19 patients requiring invasive mechanical ventilation regardless of their severity.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Le Terrier C, Sigaud F, Lebbah S, et al. Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network-the ProneCOVID study. Crit Care. 2022. PMID: 35331332. doi:10.1186/s13054-022-03949-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。